New drugs and treatment targets in psoriasis.


In recent years, the increased understanding of the pathophysiology of psoriasis has resulted in several new treatments. The success of ustekinumab proved the importance of the IL-23/T helper cell 17 axis in psoriatic diseases. Several new biologics targeting this axis will reach the clinic in the next years. Biologics are costly, require injections, and… (More)
DOI: 10.2340/00015555-1931

1 Figure or Table


  • Presentations referencing similar topics